Ajanta Pharma announced the launch of Montelukast Sodium IR Tablets and Montelukast Sodium Chewable Tablets, the generic version of Merck‘s Singulair Tablets and Singulair Chewable Tablets, respectively.
Singulair Tablets and Singulair Chewable Tablets are indicated for seasonal allergic rhinitis for patients ≥2yrs old, perennial allergic rhinitis for patients ≥6 months old, for the prophylaxis and chronic treatment of asthma for patients ≥12 months old, and for the prevention of exercise-induced bronchoconstriction (EIB) for patients ≥6yrs old. Singulair is a leukotriene receptor antagonist.
Montelukast Sodium IR Tablets are available in 10mg strength. Montelukast Sodium Chewable Tablets are available in 4mg and 5mg strengths.
For more information call (866) 770-3029 or visit Ajantapharmausa.com.